secwatch.observer — SEC 8-K summary
======================================

Issuer:     Vivos Therapeutics, Inc. (VVOS)
CIK:        0001716166
Form:       8-K
Filed at:   2024-02-15T23:59:59+00:00
Accession:  0001493152-24-006821
Event type: other_material
Sentiment:  neutral
Materiality: 0.55
Item codes: 1.01, 3.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Vivos Therapeutics raises ~$4.0M via warrant exercise; issues new inducement warrants
--------------------------------------------------------------------------------

- Holder exercises Series B warrant for cash at $4.02/share, yielding ~$4.0M gross proceeds.
- Company issues 5-year Series B-1 and 18-month Series B-2 warrants for 735,296 shares each at $5.05.
- Inducement transaction expected to close by Feb 20, 2024; proceeds for working capital.
- A.G.P./Alliance Global Partners receives 7% cash fee ($280K) plus up to $30K legal expenses.
- Company must file resale registration for new warrant shares by Apr 5, 2024.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1716166/000149315224006821/0001493152-24-006821-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1716166/000149315224006821/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-24-006821

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer